Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults
Identifieur interne : 000920 ( Pmc/Corpus ); précédent : 000919; suivant : 000921Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults
Auteurs : Yanjun Guo ; Shuhui Wang ; Bin Jiang ; Jianle Li ; Lei Liu ; Jiawei Wang ; Weiqin Zhao ; Jianping JiaSource :
- Neuropsychiatric Disease and Treatment [ 1176-6328 ] ; 2017.
Abstract
Approximately 200 cases of mild encephalitis with reversible splenial (MERS) and deep cerebral white matter lesions have been reported since MERS was first defined in 2004. MERS occurs more frequently in children; in adults, only ~60 cases have been reported. Until now, only four cases of MERS in adults have been associated with Epstein–Barr virus (EBV).
We report three adult cases of MERS associated with EBV infection in China. For all three patients, cranial magnetic resonance imaging (MRI) indicated solitary reversible splenial and/or perilateral ventricle white matter lesions with reduced diffusion. In the present report, all patients were adults presenting with high fever, headache, apathy, and confusion, as well as significant signs of meningeal inflammation. These symptoms peaked 10–14 days after disease onset, with serious hyponatremia (112–129 mmol/L), an elevated cerebrospinal fluid white blood cell count (80–380/mm3), and significantly increased protein levels (1,010–1,650 mg/dL). Cranial MRI indicated abnormal signal intensity in the splenium of corpus callosum and symmetrically reversible lesions scattered in the thalamus and deep cerebral white matter. The clinical symptoms tended to improve after ~10–14 days of antiviral treatment. However, these patients recovered more slowly than patients with viral meningitis.
MERS associated with EBV infection in adults occurs less frequently but with more severe symptoms than in children. EBV infection should be considered for patients with MERS symptoms. MERS has a good prognosis.
Url:
DOI: 10.2147/NDT.S135510
PubMed: 28831257
PubMed Central: 5548266
Links to Exploration step
PMC:5548266Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults</title><author><name sortKey="Guo, Yanjun" sort="Guo, Yanjun" uniqKey="Guo Y" first="Yanjun" last="Guo">Yanjun Guo</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Wang, Shuhui" sort="Wang, Shuhui" uniqKey="Wang S" first="Shuhui" last="Wang">Shuhui Wang</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Jiang, Bin" sort="Jiang, Bin" uniqKey="Jiang B" first="Bin" last="Jiang">Bin Jiang</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Li, Jianle" sort="Li, Jianle" uniqKey="Li J" first="Jianle" last="Li">Jianle Li</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Liu, Lei" sort="Liu, Lei" uniqKey="Liu L" first="Lei" last="Liu">Lei Liu</name><affiliation><nlm:aff id="af2-ndt-13-2085">Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Wang, Jiawei" sort="Wang, Jiawei" uniqKey="Wang J" first="Jiawei" last="Wang">Jiawei Wang</name><affiliation><nlm:aff id="af2-ndt-13-2085">Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Zhao, Weiqin" sort="Zhao, Weiqin" uniqKey="Zhao W" first="Weiqin" last="Zhao">Weiqin Zhao</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Jia, Jianping" sort="Jia, Jianping" uniqKey="Jia J" first="Jianping" last="Jia">Jianping Jia</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">28831257</idno><idno type="pmc">5548266</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548266</idno><idno type="RBID">PMC:5548266</idno><idno type="doi">10.2147/NDT.S135510</idno><date when="2017">2017</date><idno type="wicri:Area/Pmc/Corpus">000920</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000920</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults</title><author><name sortKey="Guo, Yanjun" sort="Guo, Yanjun" uniqKey="Guo Y" first="Yanjun" last="Guo">Yanjun Guo</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Wang, Shuhui" sort="Wang, Shuhui" uniqKey="Wang S" first="Shuhui" last="Wang">Shuhui Wang</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Jiang, Bin" sort="Jiang, Bin" uniqKey="Jiang B" first="Bin" last="Jiang">Bin Jiang</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Li, Jianle" sort="Li, Jianle" uniqKey="Li J" first="Jianle" last="Li">Jianle Li</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Liu, Lei" sort="Liu, Lei" uniqKey="Liu L" first="Lei" last="Liu">Lei Liu</name><affiliation><nlm:aff id="af2-ndt-13-2085">Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Wang, Jiawei" sort="Wang, Jiawei" uniqKey="Wang J" first="Jiawei" last="Wang">Jiawei Wang</name><affiliation><nlm:aff id="af2-ndt-13-2085">Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Zhao, Weiqin" sort="Zhao, Weiqin" uniqKey="Zhao W" first="Weiqin" last="Zhao">Weiqin Zhao</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author><author><name sortKey="Jia, Jianping" sort="Jia, Jianping" uniqKey="Jia J" first="Jianping" last="Jia">Jianping Jia</name><affiliation><nlm:aff id="af1-ndt-13-2085">Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</nlm:aff></affiliation></author></analytic><series><title level="j">Neuropsychiatric Disease and Treatment</title><idno type="ISSN">1176-6328</idno><idno type="eISSN">1178-2021</idno><imprint><date when="2017">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Approximately 200 cases of mild encephalitis with reversible splenial (MERS) and deep cerebral white matter lesions have been reported since MERS was first defined in 2004. MERS occurs more frequently in children; in adults, only ~60 cases have been reported. Until now, only four cases of MERS in adults have been associated with Epstein–Barr virus (EBV).</p></sec><sec><title>Case presentation</title><p>We report three adult cases of MERS associated with EBV infection in China. For all three patients, cranial magnetic resonance imaging (MRI) indicated solitary reversible splenial and/or perilateral ventricle white matter lesions with reduced diffusion. In the present report, all patients were adults presenting with high fever, headache, apathy, and confusion, as well as significant signs of meningeal inflammation. These symptoms peaked 10–14 days after disease onset, with serious hyponatremia (112–129 mmol/L), an elevated cerebrospinal fluid white blood cell count (80–380/mm<sup>3</sup>), and significantly increased protein levels (1,010–1,650 mg/dL). Cranial MRI indicated abnormal signal intensity in the splenium of corpus callosum and symmetrically reversible lesions scattered in the thalamus and deep cerebral white matter. The clinical symptoms tended to improve after ~10–14 days of antiviral treatment. However, these patients recovered more slowly than patients with viral meningitis.</p></sec><sec><title>Conclusion</title><p>MERS associated with EBV infection in adults occurs less frequently but with more severe symptoms than in children. EBV infection should be considered for patients with MERS symptoms. MERS has a good prognosis.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Tada, H" uniqKey="Tada H">H Tada</name></author><author><name sortKey="Takanashi, J" uniqKey="Takanashi J">J Takanashi</name></author><author><name sortKey="Barkovich, Aj" uniqKey="Barkovich A">AJ Barkovich</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takanashi, J" uniqKey="Takanashi J">J Takanashi</name></author><author><name sortKey="Tada, H" uniqKey="Tada H">H Tada</name></author><author><name sortKey="Maeda, M" uniqKey="Maeda M">M Maeda</name></author><author><name sortKey="Suzuki, M" uniqKey="Suzuki M">M Suzuki</name></author><author><name sortKey="Terada, H" uniqKey="Terada H">H Terada</name></author><author><name sortKey="Barkovich, Aj" uniqKey="Barkovich A">AJ Barkovich</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kosami, K" uniqKey="Kosami K">K Kosami</name></author><author><name sortKey="Kenzaka, T" uniqKey="Kenzaka T">T Kenzaka</name></author><author><name sortKey="Sagara, Y" uniqKey="Sagara Y">Y Sagara</name></author><author><name sortKey="Minami, K" uniqKey="Minami K">K Minami</name></author><author><name sortKey="Matsumura, M" uniqKey="Matsumura M">M Matsumura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takanashi, J" uniqKey="Takanashi J">J Takanashi</name></author><author><name sortKey="Shiihara, T" uniqKey="Shiihara T">T Shiihara</name></author><author><name sortKey="Hasegawa, T" uniqKey="Hasegawa T">T Hasegawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pan, Jj" uniqKey="Pan J">JJ Pan</name></author><author><name sortKey="Zhao, Yy" uniqKey="Zhao Y">YY Zhao</name></author><author><name sortKey="Lu, C" uniqKey="Lu C">C Lu</name></author><author><name sortKey="Hu, Yh" uniqKey="Hu Y">YH Hu</name></author><author><name sortKey="Yang, Y" uniqKey="Yang Y">Y Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ka, A" uniqKey="Ka A">A Ka</name></author><author><name sortKey="Britton, P" uniqKey="Britton P">P Britton</name></author><author><name sortKey="Troedson, C" uniqKey="Troedson C">C Troedson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takanashi, J" uniqKey="Takanashi J">J Takanashi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kashiwagi, M" uniqKey="Kashiwagi M">M Kashiwagi</name></author><author><name sortKey="Tanabe, T" uniqKey="Tanabe T">T Tanabe</name></author><author><name sortKey="Shimakawa, S" uniqKey="Shimakawa S">S Shimakawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lin, Fy" uniqKey="Lin F">FY Lin</name></author><author><name sortKey="Yang, Cy" uniqKey="Yang C">CY Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chacko, J" uniqKey="Chacko J">J Chacko</name></author><author><name sortKey="Pramod, K" uniqKey="Pramod K">K Pramod</name></author><author><name sortKey="Sinha, S" uniqKey="Sinha S">S Sinha</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ko, Sy" uniqKey="Ko S">SY Ko</name></author><author><name sortKey="Kim, Bk" uniqKey="Kim B">BK Kim</name></author><author><name sortKey="Kim, Dw" uniqKey="Kim D">DW Kim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hoshino, A" uniqKey="Hoshino A">A Hoshino</name></author><author><name sortKey="Saitoh, M" uniqKey="Saitoh M">M Saitoh</name></author><author><name sortKey="Oka, A" uniqKey="Oka A">A Oka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hakyemez, B" uniqKey="Hakyemez B">B Hakyemez</name></author><author><name sortKey="Erdogan, C" uniqKey="Erdogan C">C Erdogan</name></author><author><name sortKey="Yildirim, N" uniqKey="Yildirim N">N Yildirim</name></author><author><name sortKey="Gokalp, G" uniqKey="Gokalp G">G Gokalp</name></author><author><name sortKey="Parlak, M" uniqKey="Parlak M">M Parlak</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Garcia Monco, Jc" uniqKey="Garcia Monco J">JC Garcia-Monco</name></author><author><name sortKey="Martinez, A" uniqKey="Martinez A">A Martinez</name></author><author><name sortKey="Brochado, Ap" uniqKey="Brochado A">AP Brochado</name></author><author><name sortKey="Saralegui, I" uniqKey="Saralegui I">I Saralegui</name></author><author><name sortKey="Cabrera, A" uniqKey="Cabrera A">A Cabrera</name></author><author><name sortKey="Beldarrain, Mg" uniqKey="Beldarrain M">MG Beldarrain</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hagemann, G" uniqKey="Hagemann G">G Hagemann</name></author><author><name sortKey="Mentzel, Hj" uniqKey="Mentzel H">HJ Mentzel</name></author><author><name sortKey="Weisser, H" uniqKey="Weisser H">H Weisser</name></author><author><name sortKey="Kunze, A" uniqKey="Kunze A">A Kunze</name></author><author><name sortKey="Terborg, C" uniqKey="Terborg C">C Terborg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takeuchi, S" uniqKey="Takeuchi S">S Takeuchi</name></author><author><name sortKey="Takasato, Y" uniqKey="Takasato Y">Y Takasato</name></author><author><name sortKey="Masaoka, H" uniqKey="Masaoka H">H Masaoka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, S" uniqKey="Zhang S">S Zhang</name></author><author><name sortKey="Feng, J" uniqKey="Feng J">J Feng</name></author><author><name sortKey="Shi, Y" uniqKey="Shi Y">Y Shi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takanashi, J" uniqKey="Takanashi J">J Takanashi</name></author><author><name sortKey="Imamura, A" uniqKey="Imamura A">A Imamura</name></author><author><name sortKey="Hayakawa, F" uniqKey="Hayakawa F">F Hayakawa</name></author><author><name sortKey="Terada, H" uniqKey="Terada H">H Terada</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="other"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="iso-abbrev">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="publisher-id">Neuropsychiatric Disease and Treatment</journal-id><journal-title-group><journal-title>Neuropsychiatric Disease and Treatment</journal-title></journal-title-group><issn pub-type="ppub">1176-6328</issn><issn pub-type="epub">1178-2021</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28831257</article-id><article-id pub-id-type="pmc">5548266</article-id><article-id pub-id-type="doi">10.2147/NDT.S135510</article-id><article-id pub-id-type="publisher-id">ndt-13-2085</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Series</subject></subj-group></article-categories><title-group><article-title>Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yanjun</given-names></name><xref ref-type="aff" rid="af1-ndt-13-2085">1</xref><xref ref-type="corresp" rid="c1-ndt-13-2085"></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Shuhui</given-names></name><xref ref-type="aff" rid="af1-ndt-13-2085">1</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="af1-ndt-13-2085">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jianle</given-names></name><xref ref-type="aff" rid="af1-ndt-13-2085">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="af2-ndt-13-2085">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jiawei</given-names></name><xref ref-type="aff" rid="af2-ndt-13-2085">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Weiqin</given-names></name><xref ref-type="aff" rid="af1-ndt-13-2085">1</xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Jianping</given-names></name><xref ref-type="aff" rid="af1-ndt-13-2085">1</xref></contrib></contrib-group><aff id="af1-ndt-13-2085"><label>1</label>Department of Neurology, Beijing Friendship Hospital, Capital Medical University. Beijing, China</aff><aff id="af2-ndt-13-2085"><label>2</label>Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China</aff><author-notes><corresp id="c1-ndt-13-2085">Correspondence: Yanjun Guo, Department of Neurology, Beijing Friendship Hospital, Capital Medical University, No 95 Yongan Road, Beijing 100050, China, Tel +86 136 4130 4226, Fax +86 010 6313 9807, Email <email>littleguo_1999@163.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>03</day><month>8</month><year>2017</year></pub-date><volume>13</volume><fpage>2085</fpage><lpage>2092</lpage><permissions><copyright-statement>© 2017 Guo et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2017</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Background</title><p>Approximately 200 cases of mild encephalitis with reversible splenial (MERS) and deep cerebral white matter lesions have been reported since MERS was first defined in 2004. MERS occurs more frequently in children; in adults, only ~60 cases have been reported. Until now, only four cases of MERS in adults have been associated with Epstein–Barr virus (EBV).</p></sec><sec><title>Case presentation</title><p>We report three adult cases of MERS associated with EBV infection in China. For all three patients, cranial magnetic resonance imaging (MRI) indicated solitary reversible splenial and/or perilateral ventricle white matter lesions with reduced diffusion. In the present report, all patients were adults presenting with high fever, headache, apathy, and confusion, as well as significant signs of meningeal inflammation. These symptoms peaked 10–14 days after disease onset, with serious hyponatremia (112–129 mmol/L), an elevated cerebrospinal fluid white blood cell count (80–380/mm<sup>3</sup>), and significantly increased protein levels (1,010–1,650 mg/dL). Cranial MRI indicated abnormal signal intensity in the splenium of corpus callosum and symmetrically reversible lesions scattered in the thalamus and deep cerebral white matter. The clinical symptoms tended to improve after ~10–14 days of antiviral treatment. However, these patients recovered more slowly than patients with viral meningitis.</p></sec><sec><title>Conclusion</title><p>MERS associated with EBV infection in adults occurs less frequently but with more severe symptoms than in children. EBV infection should be considered for patients with MERS symptoms. MERS has a good prognosis.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>mild encephalitis with reversible splenial lesions</kwd><kwd>Epstein-Barr virus</kwd><kwd>apathy</kwd><kwd>hyponatremia</kwd><kwd>corpus fluid</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Clinically mild encephalitis/encephalopathy with a reversible splenial (MERS) lesion is a new clinico-radiological syndrome.<xref rid="b1-ndt-13-2085" ref-type="bibr">1</xref> MERS has a benign clinical course and is characterized on magnetic resonance imaging (MRI) by reversible splenial lesions with reduced diffusion. MERS occurs more commonly in children in Japan and East Asia.<xref rid="b1-ndt-13-2085" ref-type="bibr">1</xref>–<xref rid="b6-ndt-13-2085" ref-type="bibr">6</xref> Epstein–Barr virus (EBV) has been associated on rare occasions with a variety of central nervous system complications,<xref rid="b1-ndt-13-2085" ref-type="bibr">1</xref>,<xref rid="b7-ndt-13-2085" ref-type="bibr">7</xref> usually in pediatric patients<xref rid="b8-ndt-13-2085" ref-type="bibr">8</xref>–<xref rid="b10-ndt-13-2085" ref-type="bibr">10</xref> and almost exclusively during acute primary infections.<xref rid="b7-ndt-13-2085" ref-type="bibr">7</xref> Here, we report three cases of adult MERS induced by EBV infection.</p></sec><sec><title>Case presentation</title><sec><title>Case 1</title><p>In May 2007, a 46-year-old man was admitted with high fever (up to 39°C), nausea, and projectile vomiting persisting for 10 days, which were accompanied with general fatigue, neck pain, and temporal bilateral blunt headache. He was somnolent, apathetic, and showed slow response. The patient showed strong signs of meningeal inflammation. The chin–sternum distance was four fingers. No paresis or sensibility deficit was detected. Laboratory results revealed hyponatremia (sodium, 112 mmol/L) and hypochloridemia (chloride, 81 mmol/L). Serum EBV IgM was negative. A lumbar puncture indicated an elevated cerebrospinal fluid (CSF) pressure of 260 mmH<sub>2</sub>O, white blood cell (WBC) count of 250×10<sup>6</sup>/L (75% monocytes, 25% neutrophils), RBC count of 0, and severe elevation of total proteins (1,418 mg/L). Glucose was normal. CSF EBV IgM antibody screens were positive. Cranial MRI (3.0 T; General Electric, Boston, MA, USA) showed meningeal enhancement without edema or swelling. Diffusion-weighted imaging (DWI) revealed a single abnormal lesion of the splenium of corpus callosum (SCC), signal hyperintensity in fluid-attenuated inversion recovery (FLAIR), and T2 without contrast enhancement (<xref ref-type="fig" rid="f1-ndt-13-2085">Figure 1</xref>).</p><p>Beginning on the day of admission, the patient received 750 mg of acyclovir intravenous drop infusion (IV) 3 times/day for 2 weeks. By day 10, symptoms were under control. Persistent hyponatremia (sodium, 116–125 mmol/L) did not respond to sodium supplementation. Inappropriate antidi-uretic hormone secretion due to meningitis was diagnosed. Daily water intake was restricted to <1 L/day, and a 7-day treatment regimen with hydrocortisone (100 mg/day, IV, twice/day) was administered beginning on day 12.</p><p>Lumbar puncture performed on day 14 showed CSF cell count was unremarkable but demonstrated elevated proteins (833 mg/L). CSF EBV IgM was negative. A subsequent cranial MRI on day 21 indicated a decrease in the area of enhancement of the cerebral pia mater and significant absorption of splenial lesions (<xref ref-type="fig" rid="f1-ndt-13-2085">Figure 1</xref>). The patient was discharged without any clinical symptoms on day 25.</p></sec><sec><title>Case 2</title><p>In February 2011, a 33-year-old male was admitted for tracheitis and febrile infection with headache, nausea, and vomiting. Initial examination revealed confusion, apathy, and neck stiffness. Neck rigidity and a chin–sternum distance of four fingers were observed. Kernig’s sign was positive. Blood sodium was 128.2 mmol/L, and chloride was 91 mmol/L. Serological EBV IgM was positive. Serum EBV antibodies showed IgM/VCA positive (1:10); IgG/VCA 1:20; IgA/VCA (−); IgA/EA (−).</p><p>On day 1, a lumbar puncture revealed high CSF pressure (220 mmH<sub>2</sub>O) and WBC count of 80×10<sup>6</sup>/L (60% monocytes, 40% neutrophils). The CSF protein content was 1,050 mg/L and Pandy’s test was positive; glucose was normal. CSF EBV antibodies test showed IgM/VCA positive (1:5); EBV IgG/VCA 1:10; EBV IgA/VCA (−); EBV IgA/EA (−).</p><p>Cranial MRI showed T2, FLAIR, and DWI signal hyper-intensities in the SCC on day 2 (<xref ref-type="fig" rid="f1-ndt-13-2085">Figure 1</xref>).</p><p>From the date of diagnosis, the patient received 750 mg of acyclovir every 8 hours for 3 weeks. By day 10, the patient regained full consciousness in the absence of headache and vomiting. Temperature returned to normal on day 11. Neck rigidity had gradually disappeared by day 14.</p><p>Hyponatremia was persistent (sodium, 125–128 mmol/L) although sodium supplementation (10% sodium chloride, 20–40 mL, intravenous glucose tolerance test, once daily) was administered from the day of admission. Beginning on day 10, daily water intake was restricted to no more than 1 L, and a 7-day treatment regimen of corticosteroids (hydrocortisone 100 mg/day, IV over 2 hours) was administered.</p><p>The patient underwent a lumbar puncture on day 14. The initial CSF pressure was 120 mmH<sub>2</sub>O. CSF WBC count was 100.0×10<sup>6</sup>/L, CSF total protein level was 123.00 mg/dL (normal range, 15–45 mg/dL), CSF chloride was 117 mmol/L (normal range, 120–132 mmol/L), and glucose was 2.16 mmol/L (normal range, 2.24–3.92 mmol/L). EBV antibody in CSF showed IgM/VCA positive (1:10); IgG/VCA 1:10; IgA/VCA (−); IgA/EA (−); while serum EBV antibodies showed IgM/VCA positive (1:10); IgG/VCA 1:20; IgA/VCA (−); IgA/EA (−).</p><p>Lumbar puncture was repeated on day 30: intracranial pressure was 90 mmH<sub>2</sub>O, WBC count was 30.0×10<sup>6</sup>/L, total protein level was 84.00 mg/dL, glucose was 2.08 mmol/L, and CSF chloride was 113 mmol/L. EBV antibody in CSF showed IgM/VCA negative (−); IgG/VCA 1:10; IgA/VCA (−); IgA/EA (−); while serum EBV antibodies showed IgM/VCA positive (1:5); IgG/VCA 1:20; IgA/VCA (−); IgA/EA (−).</p><p>The initial MRI on day 2 showed abnormal signals in the SCC only. T1 showed equal signal intensity. T2 and FLAIR showed high signal intensity. DWI showed high signal intensity of the corpus callosum lesions without enhancement and the leptomeninges showed slight enhancement (<xref ref-type="fig" rid="f2-ndt-13-2085">Figure 2</xref>, row 1). The MRI on day 26 showed that the splenium corpus callosum lesions had almost disappeared, but showed symmetric interspersed lesions in bilateral periventricular white matter (<xref ref-type="fig" rid="f2-ndt-13-2085">Figure 2</xref>, row 2). Cranial MRI performed on day 35 showed absence of abnormal meningeal enhancement, and absence of hyper-intensity in the splenial lesions on the T2-weighted and DWI images; most of the abnormal signal in bilateral periventricular white matter disappeared, while a small lesion in the white matter in right basal ganglia did not diminish (<xref ref-type="fig" rid="f2-ndt-13-2085">Figure 2</xref>, row 3). The patient was discharged on day 42 because of clinical recovery. Cranial MRI follow-up was carried out on day 105, with similar abnormal MRI results as on day 35 (data not shown). With a clinical follow-up for 3 years, the patient remained healthy.</p></sec><sec><title>Case 3</title><p>In September 2012, a 23-year-old man was admitted due to headache with high fever (39°C), nausea, and vomiting persisting for 8 days, hiccups for 3 days, and somnolence for 2 days. On admission, his eyes could not be entirely abducted, and he showed symptoms of confusion, apathy, neck stiffness, and nystagmus. The finger-to-nose test revealed bilateral instability and inaccuracies. The neck was rigid with neck resistance and a chin–sternum distance of 4 fingers width and the Kernig’s sign was bilaterally positive. Brudzinski’s sign was bilaterally negative.</p><p>On day 1, blood WBC count was 8.31×10<sup>9</sup>/L (68.1% neutrophils), and platelet level was 319×10<sup>9</sup>/L. Sodium was 128 mmol/L, chloride was 90 mmol/L, lactate dehydrogenase (LDH) was 251 U/L, and creatine kinase (CK) was 314 U/L. On day 2, CSF analysis showed intracranial pressure at 170 mmH<sub>2</sub>O, WBC count of 380×10<sup>6</sup>/L (80% monocytes, 20% neutrophils), positive Pandy test, total proteins of 113 mg/dL, glucose of 2.64 mmol/L, and chloride of 108 mmol/L. CSF EBV IgM/VCA was positive (1:10), IgG/VCA was also 1:10 screens for IgA/VCA, and IgM/EA was negative. Blood EBV IgM/VCA was positive (1:5), IgG/VCA was also 1:20, and IgA/VCA and IgM/EA were also negative. Polymerase chain reaction (PCR) assay revealed an EBV viral load of 3.2×10<sup>3</sup> copies/L.</p><p>A cranial MRI on day 7 showed abnormal signal intensities in the SCC and white matter periventricle (<xref ref-type="fig" rid="f3-ndt-13-2085">Figure 3</xref>). Significant enhancements of the cerebral pia mater and right tentorium of the cerebellum were observed, indicating possible meningitis.</p><p>Antiviral treatment began on day 2 consisting of acyclovir (0.85 mg every 8 hours), mannitol (250 mL every 8 hours), and restricted water intake and sodium supplementation. Consciousness improved on day 9, and a blood sodium concentration of 135 mmol/L was achieved on day 10. Signs of meningeal inflammation and bilateral lower extremity pain gradually disappeared by day 12. Bilateral nystagmus had resolved on physical examination on day 13. On day 21, blood CK and LDH were normal, CSF pressure was 90 mmH<sub>2</sub>O, WBC count was 38 A cranial MRI on day 7 showed abnormal signal intensities in the SCC and white matter periventricle (<xref ref-type="fig" rid="f3-ndt-13-2085">Figure 3</xref>). Significant enhancements 10<sup>6</sup>/L, monocyte content was 90%, total proteins was 95 mg/dL, and chloride was 117 mmol/L. The patient was discharged on day 30. On day 30, cranial MRI showed that lesions in the SCC almost disappeared. Abnormal signal intensity in bilateral periventricle white matter reduced. Contrast enhancement of the cerebral pia mater significantly decreased. The enhancement of the tentorium of right cerebellum mildly decreased (<xref ref-type="fig" rid="f3-ndt-13-2085">Figure 3</xref>). However, FLAIR MRI was not carried out, because the patient refused.</p><p>Characteristics of the three adult cases of MERS associated with EBV infection are outlined in <xref ref-type="table" rid="t1-ndt-13-2085">Table 1</xref>.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>MERS typically presents as clinically mild encephalitis or encephalopathy, characterized by reversible splenial lesions with reduced diffusion on MRI, and a clinically benign course.<xref rid="b2-ndt-13-2085" ref-type="bibr">2</xref>,<xref rid="b8-ndt-13-2085" ref-type="bibr">8</xref> MERS accounts for ~16% of all cases of encephalitis in children in Japan; 34% of these cases are associated with influenza virus infection<xref rid="b9-ndt-13-2085" ref-type="bibr">9</xref> and the remaining cases are associated with rotavirus infection, mumps vaccination, and other viruses.<xref rid="b4-ndt-13-2085" ref-type="bibr">4</xref>,<xref rid="b11-ndt-13-2085" ref-type="bibr">11</xref>,<xref rid="b12-ndt-13-2085" ref-type="bibr">12</xref> One pediatric case was associated with EBV, but with a normal CSF cell count.<xref rid="b13-ndt-13-2085" ref-type="bibr">13</xref> In a series of 54 children with MERS, the prodromal syndromes were fever, vomiting, diarrhea, and cough.<xref rid="b7-ndt-13-2085" ref-type="bibr">7</xref> The neurological symptoms occurred 1–3 days after prodromal syndromes in 71% of these patients. In another series of 30 children with MERS, hyponatremia occurred in 25 children.<xref rid="b2-ndt-13-2085" ref-type="bibr">2</xref> In a series of 22 children with MERS, decreased serum sodium was observed in 18 patients, with normal CSF.<xref rid="b8-ndt-13-2085" ref-type="bibr">8</xref></p><p>Compared with the literature, the present case reports suggest that MERS could be more severe in adults than in children. Among the rare adult case reports, we found two cases of EBV encephalitis,<xref rid="b9-ndt-13-2085" ref-type="bibr">9</xref>,<xref rid="b10-ndt-13-2085" ref-type="bibr">10</xref> one of tick-borne encephalitis (CSF WBC 33/μL),<xref rid="b13-ndt-13-2085" ref-type="bibr">13</xref> one of anti-Yo rhombencephalitis,<xref rid="b14-ndt-13-2085" ref-type="bibr">14</xref> one of viral encephalitis of unknown etiology (CSF WBC 408/μL),<xref rid="b15-ndt-13-2085" ref-type="bibr">15</xref> one of influenza virus A encephalitis, one of HIV encephalitis, and some cases of MERS associated with systemic infections.<xref rid="b11-ndt-13-2085" ref-type="bibr">11</xref>,<xref rid="b16-ndt-13-2085" ref-type="bibr">16</xref>,<xref rid="b17-ndt-13-2085" ref-type="bibr">17</xref> Among these cases, CSF WBC count and protein level were both unremarkable. Alleviation of clinical symptoms and imaging changes were achieved within a short period of time.</p><p>Only four cases were reported as encephalitis with reversible splenial and deep cerebral white matter lesions associated with EBV. In the first case, a 21-year-old man presented with fever, somnolence, and disorientation.<xref rid="b15-ndt-13-2085" ref-type="bibr">15</xref> Laboratory tests showed CSF WBC count at 18/μL and protein levels at 1,500 mg/L. Cranial MRI showed focal splenial and temporal and occipital lesions. His medical condition improved with antiviral treatment. On day 21, MRI indicated disappearance of the lesions.<xref rid="b15-ndt-13-2085" ref-type="bibr">15</xref> In the second case, a 20-year-old man presented with fever, headache, consciousness, neck rigidity, CSF WBC count of 14/μL, and protein levels of 1,607 mg/L. The abnormal signal intensity in the SCC resolved after 16 days of treatment.<xref rid="b16-ndt-13-2085" ref-type="bibr">16</xref> An 8-year-old Chinese girl was admitted with generalized tonic–clonic seizures and mental deterioration following 1 day of prodromal symptoms consisting of severe headache with vomiting and high fever (40.0°C).<xref rid="b17-ndt-13-2085" ref-type="bibr">17</xref> CSF showed an abnormal cell count (125×10<sup>6</sup> cells/L, 75% lymphocytes) and protein level of 11 mg/dL. DWI revealed high signal intensities and widespread cortical and splenial lesions. She completely recovered with complete disappearance of the MRI lesions by day 28. Another 6-year-old patient with MERV was associated with EBV infection, but with a normal CSF cell count.<xref rid="b13-ndt-13-2085" ref-type="bibr">13</xref></p><p>In the present report, all patients were adults presenting with high fever, headache, apathy, and confusion, as well as significant signs of meningeal inflammation, but without epileptic seizure. These symptoms peaked 10–14 days after disease onset, with serious hyponatremia (112–129 mmol/L), an elevated CSF WBC count (80–380/mm<sup>3</sup>) (predominantly monocytes), and significantly increased protein levels (1,010–1,650 mg/dL). Cranial MRI indicated abnormal signal intensity in the SCC and symmetrically reversible lesions scattered in the thalamus and deep cerebral white matter. The clinical symptoms tended to improve after ~10–14 days of antiviral treatment. Clinical cure was achieved after ~3 weeks, and resolution of the lesions was observed within 3–14 weeks.</p><p>The altered states of consciousness and signs of meningeal inflammation noted in EBV-associated MERS in the present report and in the cases presented above seem more severe than in patients with non-herpes simplex virus encephalitis-associated MERS.<xref rid="b9-ndt-13-2085" ref-type="bibr">9</xref> In addition, these symptoms and signs observed in adults seem to be more severe and with prolonged duration compared with those of children with MERS.<xref rid="b12-ndt-13-2085" ref-type="bibr">12</xref></p><p>Among the three cases presented here, MRI of case 1 showed an isolated SCC lesion (type 1), while MRI of the two other cases showed extensive lesions in the deep cerebral white matter and entire corpus callosum with homogenously reduced diffusion (type 2). Deep cerebral white matter lesions were also observed in two other cases of EBV-associated MERS reported in the literature.<xref rid="b15-ndt-13-2085" ref-type="bibr">15</xref>,<xref rid="b16-ndt-13-2085" ref-type="bibr">16</xref> Case 2 showed a type 2 lesion (symmetrical lesions in deep cerebral white matter) that appeared after the complete resolution of type 1 lesion (isolated SCC), which showed a different time course compared with a case reported by Takanashi et al.<xref rid="b18-ndt-13-2085" ref-type="bibr">18</xref></p></sec><sec><title>Conclusion</title><p>Encephalitis with reversible splenial and/or deep cerebral white matter lesions in adults is characterized by severe clinical conditions and altered states of consciousness, usually complicated by hyponatremia and urine retention. MERS can be associated with EBV infection and has a good prognosis with antiviral treatment. Complete resolution of clinical symptoms and features can be achieved, as revealed by MRI. When patients present with symptoms of MERS, special attention should be given to serological or PCR testing of possible pathogens, in particular EBV.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the National Natural Science Foundation of China (grant number 81301032) and China Scholarship Council, Liujinfa (grant number [2016]3035: 201608110052). The funding sources had no role in the study design, data collection, and analysis.</p><p>Written informed consent for publication of this case series was obtained from patients.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ndt-13-2085"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tada</surname><given-names>H</given-names></name><name><surname>Takanashi</surname><given-names>J</given-names></name><name><surname>Barkovich</surname><given-names>AJ</given-names></name><etal></etal></person-group><article-title>Clinically mild encephalitis/encephalopathy with a reversible splenial lesion</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>1854</fpage><lpage>1858</lpage><pub-id pub-id-type="pmid">15557501</pub-id></element-citation></ref><ref id="b2-ndt-13-2085"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanashi</surname><given-names>J</given-names></name><name><surname>Tada</surname><given-names>H</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Terada</surname><given-names>H</given-names></name><name><surname>Barkovich</surname><given-names>AJ</given-names></name></person-group><article-title>Encephalopathy with a reversible splenial lesion is associated with hyponatremia</article-title><source>Brain Dev</source><year>2009</year><volume>31</volume><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">18490123</pub-id></element-citation></ref><ref id="b3-ndt-13-2085"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosami</surname><given-names>K</given-names></name><name><surname>Kenzaka</surname><given-names>T</given-names></name><name><surname>Sagara</surname><given-names>Y</given-names></name><name><surname>Minami</surname><given-names>K</given-names></name><name><surname>Matsumura</surname><given-names>M</given-names></name></person-group><article-title>Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report</article-title><source>BMC Infect Dis</source><year>2016</year><volume>16</volume><fpage>160</fpage><pub-id pub-id-type="pmid">27091490</pub-id></element-citation></ref><ref id="b4-ndt-13-2085"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanashi</surname><given-names>J</given-names></name><name><surname>Shiihara</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination</article-title><source>J Neurol Sci</source><year>2015</year><volume>349</volume><fpage>226</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">25542078</pub-id></element-citation></ref><ref id="b5-ndt-13-2085"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>JJ</given-names></name><name><surname>Zhao</surname><given-names>YY</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>YH</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><article-title>Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review</article-title><source>Neurol Sci</source><year>2015</year><volume>36</volume><fpage>2043</fpage><lpage>2051</lpage><pub-id pub-id-type="pmid">26130145</pub-id></element-citation></ref><ref id="b6-ndt-13-2085"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ka</surname><given-names>A</given-names></name><name><surname>Britton</surname><given-names>P</given-names></name><name><surname>Troedson</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis</article-title><source>Eur J Paediatr Neurol</source><year>2015</year><volume>19</volume><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">25707871</pub-id></element-citation></ref><ref id="b7-ndt-13-2085"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanashi</surname><given-names>J</given-names></name></person-group><article-title>Two newly proposed infectious encephalitis/encephalopathy syndromes</article-title><source>Brain Dev</source><year>2009</year><volume>31</volume><fpage>521</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">19339128</pub-id></element-citation></ref><ref id="b8-ndt-13-2085"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwagi</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>T</given-names></name><name><surname>Shimakawa</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Clinico-radiological spectrum of reversible splenial lesions in children</article-title><source>Brain Dev</source><year>2014</year><volume>36</volume><fpage>330</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">23790266</pub-id></element-citation></ref><ref id="b9-ndt-13-2085"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>FY</given-names></name><name><surname>Yang</surname><given-names>CY</given-names></name></person-group><article-title>Reversible splenial lesion of the corpus callosum in migraine with aura</article-title><source>Neurologist</source><year>2011</year><volume>17</volume><fpage>157</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">21532386</pub-id></element-citation></ref><ref id="b10-ndt-13-2085"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacko</surname><given-names>J</given-names></name><name><surname>Pramod</surname><given-names>K</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Clinical, neuroimaging and pathological features of 5-nitroimidazole-induced encephalo-neuropathy in two patients: insights into possible pathogenesis</article-title><source>Neurol India</source><year>2011</year><volume>59</volume><fpage>743</fpage><lpage>747</lpage><pub-id pub-id-type="pmid">22019662</pub-id></element-citation></ref><ref id="b11-ndt-13-2085"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>BK</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><etal></etal></person-group><article-title>Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy</article-title><source>Clin Mol Hepatol</source><year>2014</year><volume>20</volume><fpage>398</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">25548747</pub-id></element-citation></ref><ref id="b12-ndt-13-2085"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>A</given-names></name><name><surname>Saitoh</surname><given-names>M</given-names></name><name><surname>Oka</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes</article-title><source>Brain Dev</source><year>2012</year><volume>34</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">21924570</pub-id></element-citation></ref><ref id="b13-ndt-13-2085"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakyemez</surname><given-names>B</given-names></name><name><surname>Erdogan</surname><given-names>C</given-names></name><name><surname>Yildirim</surname><given-names>N</given-names></name><name><surname>Gokalp</surname><given-names>G</given-names></name><name><surname>Parlak</surname><given-names>M</given-names></name></person-group><article-title>Transient splenial lesion of corpus callosum associated with antiepileptic drug: conventional and diffusion-weighted magnetic resonance images</article-title><source>Acta Radiol</source><year>2005</year><volume>46</volume><fpage>734</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">16372694</pub-id></element-citation></ref><ref id="b14-ndt-13-2085"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Monco</surname><given-names>JC</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Brochado</surname><given-names>AP</given-names></name><name><surname>Saralegui</surname><given-names>I</given-names></name><name><surname>Cabrera</surname><given-names>A</given-names></name><name><surname>Beldarrain</surname><given-names>MG</given-names></name></person-group><article-title>Isolated and reversible lesions of the corpus callosum: a distinct entity</article-title><source>J Neuroimaging</source><year>2010</year><volume>20</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">19747237</pub-id></element-citation></ref><ref id="b15-ndt-13-2085"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagemann</surname><given-names>G</given-names></name><name><surname>Mentzel</surname><given-names>HJ</given-names></name><name><surname>Weisser</surname><given-names>H</given-names></name><name><surname>Kunze</surname><given-names>A</given-names></name><name><surname>Terborg</surname><given-names>C</given-names></name></person-group><article-title>Multiple reversible MR signal changes caused by Epstein–Barr virus encephalitis</article-title><source>AJNR Am J Neuroradiol</source><year>2006</year><volume>27</volume><fpage>1447</fpage><lpage>1449</lpage><pub-id pub-id-type="pmid">16908555</pub-id></element-citation></ref><ref id="b16-ndt-13-2085"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Takasato</surname><given-names>Y</given-names></name><name><surname>Masaoka</surname><given-names>H</given-names></name></person-group><article-title>Epstein–Barr virus encephalitis with a reversible splenial lesion</article-title><source>Intern Med</source><year>2012</year><volume>51</volume><fpage>341</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">22293819</pub-id></element-citation></ref><ref id="b17-ndt-13-2085"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Transient widespread cortical and splenial lesions in acute encephalitis/encephalopathy associated with primary Epstein–Barr virus infection</article-title><source>Int J Infect Dis</source><year>2016</year><volume>42</volume><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">26600186</pub-id></element-citation></ref><ref id="b18-ndt-13-2085"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanashi</surname><given-names>J</given-names></name><name><surname>Imamura</surname><given-names>A</given-names></name><name><surname>Hayakawa</surname><given-names>F</given-names></name><name><surname>Terada</surname><given-names>H</given-names></name></person-group><article-title>Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)</article-title><source>J Neurol Sci</source><year>2010</year><volume>292</volume><fpage>24</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">20236662</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ndt-13-2085" position="float"><label>Figure 1</label><caption><p>MRI of case 1.</p><p><bold>Notes:</bold> On the day of admission, abnormal signal intensity in the splenium of corpus callosum with iso-signal intensity on T1-weighted images, mild hypersignal intensity on T2-weighted images and without contrast enhancement of splenial lesions, and hypersignal intensity on FLAIR and DWI images were observed. After 21 days of treatment, second cranial MRI indicated significant absorption of splenial lesions compared with the first scan and obviously decreased area of enhancement of the cerebral pia mater.</p><p><bold>Abbreviations:</bold> FLAIR, fluid-attenuated inversion recovery; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.</p></caption><graphic xlink:href="ndt-13-2085Fig1"></graphic></fig><fig id="f2-ndt-13-2085" position="float"><label>Figure 2</label><caption><p>Magnetic resonance imaging of case 2.</p><p><bold>Notes:</bold> On the day of admission, abnormal signal intensity in the splenium of corpus callosum with iso-signal intensity on T1-weighted images, mild hypersignal intensity on T2-weighted images, mild enhancement of the meninges and lack of contrast enhancement of splenial lesions, and hypersignal intensity on DWI and FLAIR images were observed. On day 26, splenium of bilateral corpus callosum lesions in the splenium of corpus callosum almost disappeared; however, abnormal signal intensity was observed in bilateral periventricular white matter. The abnormal enhancement of meninges decreased. On day 35, abnormal signal intensity in the bilateral periventricular white matter almost disappeared.</p><p><bold>Abbreviations:</bold> FLAIR, fluid-attenuated inversion recovery; DWI, diffusion-weighted imaging.</p></caption><graphic xlink:href="ndt-13-2085Fig2"></graphic></fig><fig id="f3-ndt-13-2085" position="float"><label>Figure 3</label><caption><p>MRI of case 3.</p><p><bold>Notes:</bold> At 7 days after admission, cranial MRI showed abnormal signal intensity in the bilateral thalamus, para-lateral ventricle white matter, and splenium of corpus callosum; iso-signal intensity on T1-weighted images; mild hypersignal intensity on T2-weighted images; significant contrast enhancement of the cerebral pia mater and tentorium of right cerebellum; hypersignal intensity in bilateral periventricular white matter and splenium of corpus callosum on DWI and FLAIR images. On day 30, cranial MRI showed that lesions in the splenium of corpus callosum almost disappeared. Abnormal signal intensity in bilateral periventricle white matter reduced. Contrast enhancement of the cerebral pia mater significantly decreased. The enhancement of the tentorium of right cerebellum mildly decreased.</p><p><bold>Abbreviations:</bold> FLAIR, fluid-attenuated inversion recovery; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.</p></caption><graphic xlink:href="ndt-13-2085Fig3"></graphic></fig><table-wrap id="t1-ndt-13-2085" position="float"><label>Table 1</label><caption><p>Characteristics of the three adult cases of MERS associated with EBV infection</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Characteristic</th><th valign="top" align="left" rowspan="1" colspan="1">Case 1</th><th valign="top" align="left" rowspan="1" colspan="1">Case 2</th><th valign="top" align="left" rowspan="1" colspan="1">Case 3</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="left" rowspan="1" colspan="1">Male</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">46</td><td valign="top" align="left" rowspan="1" colspan="1">33</td><td valign="top" align="left" rowspan="1" colspan="1">23</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>On admission</bold></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Body temperature</td><td valign="top" align="left" rowspan="1" colspan="1">39°C</td><td valign="top" align="left" rowspan="1" colspan="1">40°C</td><td valign="top" align="left" rowspan="1" colspan="1">39.3°C</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Clinical symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">Fever, headache, and vomiting for 10 days</td><td valign="top" align="left" rowspan="1" colspan="1">Fever, headache, and vomiting for 10 days</td><td valign="top" align="left" rowspan="1" colspan="1">Fever, headache, and vomiting for 14 days</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Physical examination</td><td valign="top" align="left" rowspan="1" colspan="1">– Apathy and slow reactions<break></break>– Positive signs of meningeal inflammation sign<break></break>– Neck rigidity and a chin-sternum distance of 4 fingers</td><td valign="top" align="left" rowspan="1" colspan="1">– Apathy<break></break>– Positive signs of meningeal inflammation<break></break>– Neck rigidity and a chin-sternum distance of 4 fingers<break></break>– Kernig’s sign (+)<break></break>– Brudzinski’s sign (−)<break></break>– Multiple enlarged lymph nodes palpable in the bilateral posterior neck, axillae, and inguinal grooves</td><td valign="top" align="left" rowspan="1" colspan="1">– Apathy<break></break>– Positive signs of meningeal inflammation<break></break>– Neck rigidity and a chin-sternum distance of 4 fingers<break></break>– Kernig’s sign (+)<break></break>– Brudzinski’s sign (−)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Blood</bold></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sodium (mmol/L)</td><td valign="top" align="left" rowspan="1" colspan="1">112</td><td valign="top" align="left" rowspan="1" colspan="1">125</td><td valign="top" align="left" rowspan="1" colspan="1">128</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chloride (mmol/L)</td><td valign="top" align="left" rowspan="1" colspan="1">81</td><td valign="top" align="left" rowspan="1" colspan="1">91.8</td><td valign="top" align="left" rowspan="1" colspan="1">117</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>CSF</bold></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">WBC (×10<sup>6</sup>/L)</td><td valign="top" align="left" rowspan="1" colspan="1">250 (75% monocytes, 25% neutrophils)</td><td valign="top" align="left" rowspan="1" colspan="1">80 (60% monocytes, 40% neutrophils)</td><td valign="top" align="left" rowspan="1" colspan="1">380 (80% monocytes, 20% neutrophils)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Protein (mg/L)</td><td valign="top" align="left" rowspan="1" colspan="1">1,418</td><td valign="top" align="left" rowspan="1" colspan="1">1,050</td><td valign="top" align="left" rowspan="1" colspan="1">1,630</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Virus detection</td><td valign="top" align="left" rowspan="1" colspan="1">EBV IgM (+)<break></break>PCR not done</td><td valign="top" align="left" rowspan="1" colspan="1">EBV IgM/VCA positive (1:5) (day 1)<break></break>EBV IgM/VCA: positive (1:10) (day 14)<break></break>EBV IgM/VCA: positive (1:5) (day 30)<break></break>EBV IgG/VCA 1:10 (for the three times)<break></break>EBV IgA/VCA (−) (for the three times)<break></break>EBV IgA/EA (−) (for the three times)<break></break>EBV PCR not done</td><td valign="top" align="left" rowspan="1" colspan="1">EBV (day 2)<break></break>EBV IgM/VCA: positive (1:10)<break></break>EBV IgG/VCA: positive (1:10)<break></break>EBV IgA/VCA: negative<break></break>EBV IgM/EA: negative<break></break>EBV PCR 3.2×10<sup>3</sup> copies/L</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Other</bold></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1">Biopsy from lymph nodes indicated atypical inflammation</td><td valign="top" align="left" rowspan="1" colspan="1">LDH, 251 U/L; CK, 314 U/L</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Therapy</bold></td><td valign="top" align="left" rowspan="1" colspan="1">Day 1<break></break>Acyclovir, 750 mg, i.v., t.i.d., for 2 weeks;<break></break>Sodium supplementation;<break></break>Day 10: Hydrocortisone, 100 mg/day, i.v. qd, for 1 week</td><td valign="top" align="left" rowspan="1" colspan="1">Day 1<break></break>Acyclovir, 750 mg, i.v., t.i.d., for 3 weeks; Sodium supplementation;<break></break>Day 10: Hydrocortisone 100 mg/day, i.v. via pump over 2 hours, for 1 week</td><td valign="top" align="left" rowspan="1" colspan="1">Day 2<break></break>Acyclovir, 0.85 mg, per 8 hours; Mannitol, 250 mL, per 8 hours; Moxifloxacin, 250 mg, qd<break></break>Sodium supplementation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Time to clinical response</td><td valign="top" align="left" rowspan="1" colspan="1">7 days</td><td valign="top" align="left" rowspan="1" colspan="1">16 days</td><td valign="top" align="left" rowspan="1" colspan="1">14 days</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Time to resolution of lesions</td><td valign="top" align="left" rowspan="1" colspan="1">20 days</td><td valign="top" align="left" rowspan="1" colspan="1">3.5 months</td><td valign="top" align="left" rowspan="1" colspan="1">1 month</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Imaging</bold></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">First cranial MRI</td><td valign="top" align="left" rowspan="1" colspan="1">– Mild enhancement of the cerebral pia mater<break></break>–Abnormal signal intensity in the splenium of corpus callosum with<break></break>– Iso-signal intensity on T1-weighted images<break></break>– Mild hypersignal intensity on T2-weighted and FLAIR images<break></break>– Hypersignal intensity on DWI images<break></break>– Lack of contrast enhancement of splenial lesions</td><td valign="top" align="left" rowspan="1" colspan="1">– Mild enhancement of the meninges<break></break>– Abnormal signal intensity in the splenium of corpus callosum with<break></break>– Iso-signal intensity on T1-weighted images<break></break>– Mild hypersignal intensity on T2-weighted and FLAIR images<break></break>– Hypersignal intensity on DWI images<break></break>– Lack of contrast enhancement of splenial lesions</td><td valign="top" align="left" rowspan="1" colspan="1">– Abnormal signal intensity in the bilateral thalamus, para-lateral ventricle white matter and splenium of corpus callosum<break></break>– Iso-signal intensity on T1-weighted images<break></break>– Mild hypersignal intensity on T2-weighted and FLAIR images<break></break>– Hypersignal intensity on DWI images<break></break>– Significant contrast enhancement of the cerebral pia mater and tentorium of right cerebellum</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Second cranial MRI scan</td><td valign="top" align="left" rowspan="1" colspan="1">– Cranial MRI indicated a decreased area of enhancement of the cerebral pia mater and significant absorption of splenial lesions compared with the first scan</td><td valign="top" align="left" rowspan="1" colspan="1">– Abnormal signal intensity in the bilateral basal ganglia, thalamus, and splenium of bilateral corpus callosums<break></break>– Lesionsin the splenium of corpus callosum almost disappeared<break></break>– Decreased signal intensity on T2WI images and resolution of hypersignal intensity on DWI images compared with the first scan<break></break>– The meninges show decreased abnormal enhancement<break></break>– New lesions noted in the bilateral basal ganglia and thalamus</td><td valign="top" align="left" rowspan="1" colspan="1">– Cranial MRI showed abnormal signal intensity in the bilateral thalamus and para-lateral ventricle and white matter lesions<break></break>– Significant contrast enhancement of the cerebral pia mater<break></break>– Mild decrease in the enhancement of the tentorium of right cerebellum<break></break>– Lesionsin the splenium of corpus callosum almost disappeared</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ndt-13-2085"><p><bold>Abbreviations:</bold> CSF, cerebrospinal fluid; DWI, diffusion-weighted imaging; EBV, Epstein–Barr virus; EA, early antigen; FLAIR, fluid-attenuated inversion recovery; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; VCA, viral capsid antigen; WBC, white blood cell.</p></fn></table-wrap-foot></table-wrap></floats-group></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000920 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000920 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:5548266
|texte= Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:28831257" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |